HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

53.900

+0.9001.70%

Volume:17.01M

Turnover:908.45M

Market Cap:31.42B

PE:-12.03

High:55.000

Open:54.350

Low:51.950

Close:53.000

52wk High:80.900

52wk Low:29.980

Shares:583.00M

HK Float Shares:583.00M

Volume Ratio:1.06

T/O Rate:2.92%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-4.480

ROE:--

ROA:-1.36%

PB:7.33

PE(LYR):-12.03

PS:29.67

Loading ...

Overview Company News Filings

Insilico Medicine Cayman Topco - Chairman Aleksandrs Zavoronkovs Initiates Share Increasing Plan Using Personal Funds

THOMSON REUTERS

INSILICO Completes US$305 Million Zero-Coupon Convertible Bond Offering, Targets R&D Expansion and AI Drug Discovery

Bulletin Express

Insilico Medicine Completes Issue of Us$305 Million Zero-Coupon Convertible Bonds Due 2027

INSILICO completes $305 million zero-coupon convertible bond issuance

Citigroup Flags AI Drug Discovery as the Next Major Industry Catalyst, Names INSILICO Top Pick with a "Buy" Rating

Movement Alert｜INSILICO Rises 5.16% in Regular Trading, MSCI Index Inclusion Effect Continues Amid Strong Earnings Momentum

Insilico Medicine Added to HKEX Tech 100 Index After Methodology Revamp

Insilico Shows Promise of Repeatable AI Drug-Creation

Insilico Medicine Surges 5% After Unveiling Novel Alzheimer's Targets in Landmark Study

Movement Alert｜INSILICO Rises 5.49% in Regular Trading, MSCI Index Inclusion Drives Passive Fund Inflows

Movement Alert｜INSILICO Falls 5.27% in Regular Trading, Convertible Bond Issuance Sparks Dilution Concerns

Insilico Medicine Cayman Enters Subscription Agreement for Us$305 Million Bonds on Aug 27

INSILICO Announces Proposed $305M Zero-Coupon Convertible Bond Offering Due 2027

Insilico Medicine Cayman Topco - Enters Subscription Agreement for Us$305 Mln Bonds on Aug 27, 2026

THOMSON REUTERS

Insilico Medicine Prices USD 305 Million Zero-Coupon Convertible Bond Offering Due 2027

InSilico Medicine (SEHK:3696) Stock Turns Profitable As Revenue Jumps

Simply Wall St.

Insilico Medicine Cayman Topco Says no Dividends were Paid, Declared or Proposed During HY

Commercialization Roadmap Validated with Three-Digit Million-Dollar Revenue: Insilico Medicine Announces Interim Results for the First Half of 2026

THOMSON REUTERS

InSilico Medicine Cayman TopCo Posts HY Profit of Us$35.5 MLN

INSILICO Delivers 1H 2026 Turnaround with Revenue Up 2.9-Fold and First Interim Profit

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/03696/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":53.9,"timestamp":1789027724005,"preClose":53,"halted":0,"volume":17013805,"delay":0,"changeRate":0.01698113207547167,"floatShares":583000000,"shares":583000000,"eps":-4.48,"marketStatus":"Closed","change":0.9,"latestTime":"09-10 16:08:44","open":54.35,"high":55,"low":51.95,"amount":908453357,"amplitude":0.057547,"askPrice":53.95,"askSize":2000,"bidPrice":53.9,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-4.006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":53,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.06069,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":583000000,"roa":"-1.36%","roe":"--","lyrEps":-4.48,"volumeRatio":1.06069,"shares":583000000,"dividePrice":0,"high":55,"amplitude":0.057547,"preClose":53,"low":51.95,"week52Low":29.98,"pbRate":"7.33","psRate":"29.67","week52High":80.9,"institutionHeld":0,"latestPrice":53.9,"committee":0.428571,"eps":-4.48,"divideRate":0,"volume":17013805,"delay":0,"ttmEps":-4.006,"open":54.35,"prevYearClose":37.14,"prevWeekClose":48.76,"prevMonthClose":43.74,"prevQuarterClose":39.62,"fiveDayClose":47,"twentyDayClose":46.38,"sixtyDayClose":32.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-30","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1786032000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-09-09","current":-13.354968,"percent":0.435294,"low":-126.474328,"twenty":-93.127559,"median":-12.517861,"eighty":-8.791356,"high":-6.819055,"avg":-40.471792,"sd":41.550192,"marketCap":30519413046},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190},{"date":"2026-02-13","current":-120.862692,"twenty":-111.02361,"median":-93.674734,"eighty":-69.411577,"marketCap":41892545100},{"date":"2026-02-20","current":-120.573146,"twenty":-113.535701,"median":-95.532684,"eighty":-72.22559,"marketCap":41778551780},{"date":"2026-02-27","current":-101.790811,"twenty":-112.276672,"median":-99.165731,"eighty":-75.603624,"marketCap":35309430870},{"date":"2026-03-06","current":-91.269503,"twenty":-111.865913,"median":-96.698006,"eighty":-83.671368,"marketCap":31633146300},{"date":"2026-03-13","current":-90.695168,"twenty":-110.462075,"median":-97.855611,"eighty":-84.923636,"marketCap":31476674990},{"date":"2026-03-20","current":-90.217416,"twenty":-108.336494,"median":-95.132264,"eighty":-85.637602,"marketCap":31333988340},{"date":"2026-03-27","current":-94.081335,"twenty":-107.867915,"median":-93.382526,"eighty":-84.923636,"marketCap":32646705520},{"date":"2026-04-02","current":-11.868567,"twenty":-107.743793,"median":-93.151788,"eighty":-79.84609,"marketCap":32770014500},{"date":"2026-04-10","current":-12.877757,"twenty":-106.637664,"median":-92.691879,"eighty":-68.00457,"marketCap":35546164200},{"date":"2026-04-17","current":-12.624497,"twenty":-104.449464,"median":-91.076584,"eighty":-59.957423,"marketCap":34802041600},{"date":"2026-04-24","current":-14.676127,"twenty":-103.459526,"median":-89.747522,"eighty":-15.148699,"marketCap":40497441500},{"date":"2026-04-30","current":-13.071473,"twenty":-103.255287,"median":-88.68986,"eighty":-14.223075,"marketCap":36089946100},{"date":"2026-05-08","current":-13.340785,"twenty":-103.091175,"median":-88.574112,"eighty":-13.384736,"marketCap":36805448600},{"date":"2026-05-15","current":-10.983422,"twenty":-102.596106,"median":-86.723486,"eighty":-13.331626,"marketCap":30308685900},{"date":"2026-05-22","current":-10.451313,"twenty":-102.308283,"median":-85.637602,"eighty":-12.881328,"marketCap":28849060800},{"date":"2026-05-29","current":-8.622113,"twenty":-102.242154,"median":-83.671368,"eighty":-12.624497,"marketCap":23800475160},{"date":"2026-06-05","current":-7.875348,"twenty":-101.790811,"median":-78.255166,"eighty":-12.515704,"marketCap":21739827960},{"date":"2026-06-12","current":-7.01543,"twenty":-100.06892,"median":-65.190557,"eighty":-12.085532,"marketCap":19370083680},{"date":"2026-06-18","current":-7.947724,"twenty":-100.046598,"median":-60.518922,"eighty":-10.958896,"marketCap":21945892680},{"date":"2026-06-26","current":-7.919554,"twenty":-99.340788,"median":-54.070713,"eighty":-10.005367,"marketCap":21877204440},{"date":"2026-07-03","current":-7.743582,"twenty":-98.690073,"median":-27.191152,"eighty":-9.565807,"marketCap":21396386760},{"date":"2026-07-10","current":-8.877372,"twenty":-98.062553,"median":-14.676127,"eighty":-8.824583,"marketCap":24510253640},{"date":"2026-07-17","current":-8.953114,"twenty":-97.4013,"median":-14.167396,"eighty":-8.882012,"marketCap":24727766400},{"date":"2026-07-24","current":-9.751189,"twenty":-96.617922,"median":-13.560542,"eighty":-8.925911,"marketCap":26937238120},{"date":"2026-07-31","current":-9.466525,"twenty":-95.411086,"median":-13.340785,"eighty":-8.88656,"marketCap":26158771400},{"date":"2026-08-07","current":-9.410567,"twenty":-94.035578,"median":-13.201047,"eighty":-8.763781,"marketCap":26009946880},{"date":"2026-08-14","current":-9.225945,"twenty":-93.733176,"median":-12.895614,"eighty":-8.825762,"marketCap":25506233120},{"date":"2026-08-21","current":-8.414722,"twenty":-93.349385,"median":-12.788902,"eighty":-8.725669,"marketCap":23250969240},{"date":"2026-08-28","current":-11.42993,"twenty":-93.240519,"median":-12.603589,"eighty":-8.725669,"marketCap":26661298566},{"date":"2026-09-04","current":-12.035257,"twenty":-93.142096,"median":-12.516782,"eighty":-8.763781,"marketCap":28077860002},{"date":"2026-09-09","current":-13.078998,"twenty":-93.127559,"median":-12.517861,"eighty":-8.791356,"marketCap":30519413046}],"updateTime":1789027304168},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664807161","title":"Insilico Medicine Cayman Topco - Chairman Aleksandrs Zavoronkovs Initiates Share Increasing Plan Using Personal Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664807161?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:00","pubTimestamp":1788480032,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44V157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123898168","title":"INSILICO Completes US$305 Million Zero-Coupon Convertible Bond Offering, Targets R&D Expansion and AI Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1123898168","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123898168?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:23","pubTimestamp":1788445393,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (INSILICO) has closed the issuance of US$305.00 million zero-coupon convertible bonds due 2027 under its general mandate, after all conditions precedent in the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870187","title":"Insilico Medicine Completes Issue of Us$305 Million Zero-Coupon Convertible Bonds Due 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870187","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870187?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:16","pubTimestamp":1788444987,"startTime":"0","endTime":"0","summary":"Insilico Medicine completes issue of US$305 million zero-coupon convertible bonds due 2027Insilico Medicine Cayman Topco completed issuance of US$ 305 million zero coupon convertible bonds due 2027.Ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL45dSkx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150646805","title":"INSILICO completes $305 million zero-coupon convertible bond issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=1150646805","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150646805?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:10","pubTimestamp":1788444649,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that all conditions precedent under the subscription agreement have been fulfilled. The zero-coupon convertible bonds, with an aggregate principal amount of $305...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNDW","03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121469399","title":"Citigroup Flags AI Drug Discovery as the Next Major Industry Catalyst, Names INSILICO Top Pick with a \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1121469399","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121469399?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:16","pubTimestamp":1788426987,"startTime":"0","endTime":"0","summary":"Citigroup's latest research report highlights that China's AI-driven drug discovery (AIDD) sector is accelerating rapidly, with the speed and cost advantages of AI drawing significant attention from...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","TFNS","BK4534","BK4588","LU0162691827.USD","BK4207","LU1791807156.HKD","LU0477156953.USD","LU1366192091.USD","LU1201861249.SGD","IE00BSNM7G36.USD","LU0648001328.SGD","VTHR","LU1267930227.SGD","LU2125154935.USD","LU0980610538.SGD","LU1506573853.SGD","IYF","LU2456880835.USD","LU0170899867.USD","LU2417539215.USD","LU1074936037.SGD","LU1244550577.SGD","LU2462157665.USD","BK4566","LU0203345920.USD","BK1617","LU0072461881.USD","LU0128525689.USD","C","02228","CHAT","LU0130517989.USD","LU1162221912.USD","BK1141","FTXO","AIPO","LU0098860793.USD","LU0320765646.SGD","BK4504","LU0314106906.USD","LU0052756011.USD","LU0106831901.USD","LU2360032135.SGD","LU1668664300.SGD","QTOC","LU0203347892.USD","LU1244550221.USD","LU2125154778.USD","LU1244550494.USD","AGIX","03696","ARTY","LU1144417596.USD","LU0310800965.SGD","LU0130102774.USD","BK4585","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165517752","title":"Movement Alert｜INSILICO Rises 5.16% in Regular Trading, MSCI Index Inclusion Effect Continues Amid Strong Earnings Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1165517752","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165517752?lang=en_us&edition=fundamental","pubTime":"2026-09-03 09:36","pubTimestamp":1788399412,"startTime":"0","endTime":"0","summary":"On September 3, INSILICO rose 5.16% in regular trading, trading at 47.3 HKD/share, with turnover of approximately 96.24 million HKD, extending its recent upward trajectory.On the news front, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"INSILICO Soars on MSCI Inclusion and H1 Revenue Up 287%","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664479708","title":"Insilico Medicine Added to HKEX Tech 100 Index After Methodology Revamp","url":"https://stock-news.laohu8.com/highlight/detail?id=2664479708","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664479708?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:31","pubTimestamp":1788395511,"startTime":"0","endTime":"0","summary":"Insilico Medicine added to HKEX Tech 100 Index after methodology revampInsilico Medicine Cayman Topco will be added to the HKEX Tech 100 Index, effective Sept. 14, 2026.The move follows HKEX methodolo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL25gWsb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842414","title":"Insilico Shows Promise of Repeatable AI Drug-Creation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842414","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842414?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:59","pubTimestamp":1788393540,"startTime":"0","endTime":"0","summary":"2359 GMT - Insilico offers one of the clearest tests of whether AI can expand pharma innovation beyond faster molecule design, Citi analysts. They start coverage with a buy/high-risk rating. Insilico has sustained preclinical candidate generation since 2021 across multiple therapeutic areas, supporting the repeatability of its AI-discovery process. The 15 partnerships with global firms it has disclosed have an aggregate headline contract value exceeding $11 billion and suggest it can convert hypotheses into development assets and commercial transactions at scale. Of the various clinical assets on track to validate Insilico's AI-driven drug design, Citi sees rentosertib--the first AIDD candidate in Phase III--as the biggest valuation catalyst. It sets a HK$85 target on the stock, which closed at HK$44.96.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","03696","QTOC","ARTY","CHAT","BK1141","AIPO","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186036617","title":"Insilico Medicine Surges 5% After Unveiling Novel Alzheimer's Targets in Landmark Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1186036617","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186036617?lang=en_us&edition=fundamental","pubTime":"2026-09-01 14:08","pubTimestamp":1788242902,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) saw its share price climb more than 5% during Tuesday afternoon trading, buoyed by the announcement of a milestone research publication. As of the latest update, the stock...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK4585","KCAI","03696","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179186375","title":"Movement Alert｜INSILICO Rises 5.49% in Regular Trading, MSCI Index Inclusion Drives Passive Fund Inflows","url":"https://stock-news.laohu8.com/highlight/detail?id=1179186375","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179186375?lang=en_us&edition=fundamental","pubTime":"2026-09-01 14:04","pubTimestamp":1788242667,"startTime":"0","endTime":"0","summary":"On September 1, INSILICO rose 5.49% in regular trading, trading at 46.1 HKD/share, with turnover of HKD 308 million, largely recovering from the decline triggered by its recent convertible bond...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"INSILICO Rises on MSCI Inclusion After Convertible Bond Dip","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157580114","title":"Movement Alert｜INSILICO Falls 5.27% in Regular Trading, Convertible Bond Issuance Sparks Dilution Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1157580114","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157580114?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:53","pubTimestamp":1788141198,"startTime":"0","endTime":"0","summary":"On August 31, INSILICO fell 5.27% in regular trading, trading at HK$43.86 per share, with turnover of HK$133 million, extending its recent downward trend.On the news front, the company signed a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"INSILICO Falls on $305M Convertible Bond Issuance Dilution Fears","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662305100","title":"Insilico Medicine Cayman Enters Subscription Agreement for Us$305 Million Bonds on Aug 27","url":"https://stock-news.laohu8.com/highlight/detail?id=2662305100","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662305100?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:50","pubTimestamp":1787881813,"startTime":"0","endTime":"0","summary":"Aug 28 (Reuters) - Insilico Medicine Cayman TopCo <3696.HK>::*ENTERS SUBSCRIPTION AGREEMENT FOR US$305 MILLION BONDS ON AUG 27, 2026*Further company coverage: 3696.HK* ((Reuters.Briefs@thomsonreuters.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nRSD4z3jtW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113505404","title":"INSILICO Announces Proposed $305M Zero-Coupon Convertible Bond Offering Due 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=1113505404","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113505404?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:28","pubTimestamp":1787873295,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that on August 27, 2026, following the close of trading, it entered into a subscription agreement with the managers. Under the terms of this agreement, and subject to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BNDW","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662003986","title":"Insilico Medicine Cayman Topco - Enters Subscription Agreement for Us$305 Mln Bonds on Aug 27, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662003986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662003986?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:24","pubTimestamp":1787869475,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1MQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662893039","title":"Insilico Medicine Prices USD 305 Million Zero-Coupon Convertible Bond Offering Due 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2662893039","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662893039?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:24","pubTimestamp":1787869463,"startTime":"0","endTime":"0","summary":"Insilico Medicine prices USD 305 million zero-coupon convertible bond offering due 2027Insilico Medicine priced a USD 305 million zero coupon convertible bonds due 2027 offering.Bonds convert at an in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL4D3LGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662847130","title":"InSilico Medicine (SEHK:3696) Stock Turns Profitable As Revenue Jumps","url":"https://stock-news.laohu8.com/highlight/detail?id=2662847130","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662847130?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:26","pubTimestamp":1787840791,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo went into this earnings print with a growth label and a rich P/S multiple, yet the real story today is the profit swing hiding behind a relatively calm share price at HK$47.02. The stock has posted steady gains over the past three months and has not reacted violently to the latest numbers, even though the company moved from heavy losses in 2025 to a H1 2026 basic EPS of US$0.062 on US$106.303 million in revenue. For a high expectation biotech platform, that...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-sehk3696-stock-turns-profitable-as-revenue","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-sehk3696-stock-turns-profitable-as-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662082790","title":"Insilico Medicine Cayman Topco Says no Dividends were Paid, Declared or Proposed During HY","url":"https://stock-news.laohu8.com/highlight/detail?id=2662082790","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662082790?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:44","pubTimestamp":1787741060,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Cayman Topco Says No Dividends Were Paid, Declared Or Proposed During HYAug 26 (Reuters)-Insilico Medicine Cayman TopCo3696.HK:NO DIVIDENDS WERE PAID, DECLARED OR PROPOSED DURING HYFurther company coverage:3696.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0HE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662192790","title":"Commercialization Roadmap Validated with Three-Digit Million-Dollar Revenue: Insilico Medicine Announces Interim Results for the First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662192790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662192790?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:38","pubTimestamp":1787740683,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nTUA5K2JQM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662791101","title":"InSilico Medicine Cayman TopCo Posts HY Profit of Us$35.5 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2662791101","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662791101?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:22","pubTimestamp":1787736131,"startTime":"0","endTime":"0","summary":"Aug 26 (Reuters) - INSILICO Medicine Cayman TopCo HY profit US$35.5 MLN.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 26-AUG-202609:05:00.637 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nRSDpRLS4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167674640","title":"INSILICO Delivers 1H 2026 Turnaround with Revenue Up 2.9-Fold and First Interim Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1167674640","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167674640?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:22","pubTimestamp":1787736129,"startTime":"0","endTime":"0","summary":"INSILICO (InSilico Medicine Cayman TopCo) reported a sharp swing to profitability in the six months ended 30 June 2026, driven by surging revenue from AI-enabled drug discovery partnerships and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"INSILICO Delivers 1H 2026 Turnaround with Revenue Up 2.9-Fold and First Interim Profit","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}